Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort
- PMID: 30455235
- PMCID: PMC6355562
- DOI: 10.1128/AAC.01384-18
Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort
Abstract
Fluconazole-induced alopecia is a significant problem for patients receiving long-term therapy. We evaluated the hair cycle changes of fluconazole in a rat model and investigated potential molecular mechanisms. Plasma and tissue levels of retinoic acid were not found to be causal. Human patients with alopecia attributed to fluconazole also underwent detailed assessment and in both our murine model and human cohort fluconazole induced telogen effluvium. Future work further examining the mechanism of fluconazole-induced alopecia should be undertaken.
Keywords: alopecia; antifungal; fluconazole; side effect.
Copyright © 2019 American Society for Microbiology.
Figures
Similar articles
-
Alopecia associated with fluconazole therapy.Ann Intern Med. 1996 Jul 15;125(2):153; author reply 153-4. doi: 10.7326/0003-4819-125-2-199607150-00020. Ann Intern Med. 1996. PMID: 8678374 No abstract available.
-
Culprits of Medication-Induced Telogen Effluvium, Part 1.Cutis. 2023 Dec;112(6):267-271. doi: 10.12788/cutis.0910. Cutis. 2023. PMID: 38290075 Review.
-
Common hair loss disorders.Am Fam Physician. 2003 Jul 1;68(1):93-102. Am Fam Physician. 2003. PMID: 12887115 Review.
-
Safety evaluation of chronic fluconazole therapy. Fluconazole Pan-American Study Group.Chemotherapy. 1997 Sep-Oct;43(5):371-7. doi: 10.1159/000239592. Chemotherapy. 1997. PMID: 9309372 Clinical Trial.
-
Tolerability of long-term fluconazole therapy.J Antimicrob Chemother. 2019 Mar 1;74(3):768-771. doi: 10.1093/jac/dky501. J Antimicrob Chemother. 2019. PMID: 30535104
Cited by
-
Aspiring Antifungals: Review of Current Antifungal Pipeline Developments.J Fungi (Basel). 2020 Feb 25;6(1):28. doi: 10.3390/jof6010028. J Fungi (Basel). 2020. PMID: 32106450 Free PMC article. Review.
-
Challenges Facing Antimicrobial Stewardship Programs in the Endemic Region for Coccidioidomycosis.Open Forum Infect Dis. 2024 Jan 24;11(6):ofae041. doi: 10.1093/ofid/ofae041. eCollection 2024 Jun. Open Forum Infect Dis. 2024. PMID: 38887479 Free PMC article. Review.
-
Chronic paronychia associated with fluconazole use in two pediatric patients with coccidioidomycosis.IDCases. 2024 Jul 3;37:e02026. doi: 10.1016/j.idcr.2024.e02026. eCollection 2024. IDCases. 2024. PMID: 39045033 Free PMC article.
-
Isavuconazole therapeutic drug monitoring and association with adverse events.J Antimicrob Chemother. 2025 Jun 3;80(6):1702-1706. doi: 10.1093/jac/dkaf128. J Antimicrob Chemother. 2025. PMID: 40289250 Free PMC article.
-
Experience of Isavuconazole as a Salvage Therapy in Chronic Pulmonary Fungal Disease.J Fungi (Basel). 2022 Mar 31;8(4):362. doi: 10.3390/jof8040362. J Fungi (Basel). 2022. PMID: 35448593 Free PMC article.
References
-
- Ashley ESD, Lewis R, Lewis JS, Martin C, Andes D. 2006. Pharmacology of systemic antifungal agents. Clin Infect Dis 43:S28–S39. doi:10.1086/504492. - DOI
-
- . 2017. Fluconazole (package insert): product monograph. Pfizer, New York, NY.